Safety and tolerability of cell culture-derived and egg-derived trivalent influenza vaccines in 3 to  | Zendy

Javier DíezDomingo | Zendy; Maurizio de Martino | Zendy; Jose Garcia-Sicilia Lopez | Zendy; Gian Vincenzo Zuccotti | Zendy; Giancarlo Icardi | Zendy; Alberto Villani | Zendy; David MorenoPérez | Zendy; María Méndez Hernández | Zendy; Javier Álvarez Aldeán | Zendy; Ahmed Abdul Mateen | Zendy; Igwebuike Enweonye | Zendy; Richard de Rooij | Zendy; Richa Chandra | Zendy

Open Access

Safety and tolerability of cell culture-derived and egg-derived trivalent influenza vaccines in 3 to <18-year-old children and adolescents at risk of influenza-related complications

Author(s) -

Javier DíezDomingo,

Maurizio de Martino,

Jose Garcia-Sicilia Lopez,

Gian Vincenzo Zuccotti,

Giancarlo Icardi,

Alberto Villani,

David MorenoPérez,

María Méndez Hernández,

Javier Álvarez Aldeán,

Ahmed Abdul Mateen,

Igwebuike Enweonye,

Richard de Rooij,

Richa Chandra

Publication year - 2016

Publication title -

international journal of infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.278

H-Index - 89

eISSN - 1878-3511

pISSN - 1201-9712

DOI - 10.1016/j.ijid.2016.06.018

Subject(s) - reactogenicity , tolerability , medicine , irritability , vaccination , adverse effect , pediatrics , influenza vaccine , live attenuated influenza vaccine , immunology , immunogenicity , immune system , menopause

This descriptive, non-comparative, phase III study evaluated the safety and tolerability of cell culture-derived (TIVc) and egg-derived (TIV) seasonal influenza vaccines in children at risk of influenza-related complications.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research